Literature DB >> 12403363

CD5, an important regulator of lymphocyte selection and immune tolerance.

Chander Raman1.   

Abstract

The CD5 coreceptor is a cysteine-rich scavenger receptor family glycoprotein that is expressed constitutively on all T cells and a subset of B cells (B I a B cells). It is now generally accepted that the biologic role of CD5 is to regulate intracellular strength induced by antigen receptors in both T and B cells. However, at present it is unclear if this coreceptor's effect on antigen receptor signaling is primarily costimulatory or inhibitory since support for both exists. Our studies focus on understanding the physiologic role of CD5 in the context of regulation of antigen receptor activation, B and T cell selection, and generation/maintenance of immune tolerance. In this overview, I discuss studies using experimental models of lymphocyte selection and tolerance showing that CD5 plays a key role in B and T cell selection as well as generation and maintenance of tolerance. I and others, reviewed here, now provide clear evidence that CD5 is a key regulator of immune tolerance and that alterations of its activity can promote development of autoreactivity.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12403363     DOI: 10.1385/IR:26:1-3:255

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  54 in total

Review 1.  B-1 cell definition.

Authors:  K Hayakawa; S A Shinton; M Asano; R R Hardy
Journal:  Curr Top Microbiol Immunol       Date:  2000       Impact factor: 4.291

Review 2.  Co-receptors on B lymphocytes.

Authors:  T Tsubata
Journal:  Curr Opin Immunol       Date:  1999-06       Impact factor: 7.486

Review 3.  CD5 signal transduction: positive or negative modulation of antigen receptor signaling.

Authors:  F Lozano; M Simarro; J Calvo; J M Vilà; O Padilla; M A Bowen; K S Campbell
Journal:  Crit Rev Immunol       Date:  2000       Impact factor: 2.214

4.  AP2 adaptor complex-dependent internalization of CD5: differential regulation in T and B cells.

Authors:  Xianghuai Lu; Robert C Axtell; James F Collawn; Andrew Gibson; Louis B Justement; Chander Raman
Journal:  J Immunol       Date:  2002-06-01       Impact factor: 5.422

Review 5.  Recent progress in the understanding of B-cell functions in autoimmunity.

Authors:  N Porakishvili; R Mageed; C Jamin; J O Pers; N Kulikova; Y Renaudineau; P M Lydyard; P Youinou
Journal:  Scand J Immunol       Date:  2001 Jul-Aug       Impact factor: 3.487

6.  CD5 transgenic mice.

Authors:  X Chen; Y Matsuura; J F Kearney
Journal:  Curr Top Microbiol Immunol       Date:  1995       Impact factor: 4.291

7.  CD5-mediated negative regulation of antigen receptor-induced growth signals in B-1 B cells.

Authors:  G Bikah; J Carey; J R Ciallella; A Tarakhovsky; S Bondada
Journal:  Science       Date:  1996-12-13       Impact factor: 47.728

8.  Disruption of the Cr2 locus results in a reduction in B-1a cells and in an impaired B cell response to T-dependent antigen.

Authors:  J M Ahearn; M B Fischer; D Croix; S Goerg; M Ma; J Xia; X Zhou; R G Howard; T L Rothstein; M C Carroll
Journal:  Immunity       Date:  1996-03       Impact factor: 31.745

9.  Regulation of casein kinase 2 by direct interaction with cell surface receptor CD5.

Authors:  C Raman; A Kuo; J Deshane; D W Litchfield; R P Kimberly
Journal:  J Biol Chem       Date:  1998-07-24       Impact factor: 5.157

10.  Identification of a novel inducible cell-surface ligand of CD5 on activated lymphocytes.

Authors:  L Biancone; M A Bowen; A Lim; A Aruffo; G Andres; I Stamenkovic
Journal:  J Exp Med       Date:  1996-09-01       Impact factor: 14.307

View more
  18 in total

Review 1.  The immunomodulatory properties of the CD5 lymphocyte receptor in health and disease.

Authors:  Gloria Soldevila; Chander Raman; Francisco Lozano
Journal:  Curr Opin Immunol       Date:  2011-04-07       Impact factor: 7.486

2.  Constitutive Phosphorylation of STAT3 by the CK2-BLNK-CD5 Complex.

Authors:  Uri Rozovski; David M Harris; Ping Li; Zhiming Liu; Preetesh Jain; Ivo Veletic; Alessandra Ferrajoli; Jan Burger; Susan O'Brien; Prithviraj Bose; Philip Thompson; Nitin Jain; William Wierda; Michael J Keating; Zeev Estrov
Journal:  Mol Cancer Res       Date:  2017-01-27       Impact factor: 5.852

3.  The CD5 ectodomain interacts with conserved fungal cell wall components and protects from zymosan-induced septic shock-like syndrome.

Authors:  Jorge Vera; Rafael Fenutría; Olga Cañadas; Maite Figueras; Rubén Mota; Maria-Rosa Sarrias; David L Williams; Cristina Casals; José Yelamos; Francisco Lozano
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-13       Impact factor: 11.205

Review 4.  Receptor-directed therapy of T-cell leukemias and lymphomas.

Authors:  John C Morris; Thomas A Waldmann; John E Janik
Journal:  J Immunotoxicol       Date:  2008-04       Impact factor: 3.000

5.  Molecular characterization of the evolution of phagosomes.

Authors:  Jonathan Boulais; Matthias Trost; Christian R Landry; Régis Dieckmann; Emmanuel D Levy; Thierry Soldati; Stephen W Michnick; Pierre Thibault; Michel Desjardins
Journal:  Mol Syst Biol       Date:  2010-10-19       Impact factor: 11.429

6.  Tuning T Cell Signaling Sensitivity Alters the Behavior of CD4+ T Cells during an Immune Response.

Authors:  Ashley A Viehmann Milam; Juliet M Bartleson; David L Donermeyer; Stephen Horvath; Vivek Durai; Saravanan Raju; Haiyang Yu; Veronika Redmann; Bernd Zinselmeyer; J Michael White; Kenneth M Murphy; Paul M Allen
Journal:  J Immunol       Date:  2018-04-04       Impact factor: 5.422

7.  CD5 dynamically calibrates basal NF-κB signaling in T cells during thymic development and peripheral activation.

Authors:  Courtney A Matson; Seeyoung Choi; Ferenc Livak; Bin Zhao; Apratim Mitra; Paul E Love; Nevil J Singh
Journal:  Proc Natl Acad Sci U S A       Date:  2020-06-08       Impact factor: 11.205

8.  Characterization of rabbit CD5 isoforms.

Authors:  Richard Pospisil; Juraj Kabat; Rose G Mage
Journal:  Mol Immunol       Date:  2009-06-10       Impact factor: 4.407

Review 9.  The three as: Alternative splicing, alternative polyadenylation and their impact on apoptosis in immune function.

Authors:  Davia Blake; Kristen W Lynch
Journal:  Immunol Rev       Date:  2021-08-08       Impact factor: 12.988

10.  Predominant VH1-69 IgBCR Clones Show Higher Expression of CD5 in Heterogeneous Chronic Lymphocytic Leukemia Populations.

Authors:  Domenico Maisano; Enrico Iaccino; Alessandro D'Ambrosio; Federico Chiurazzi; Vincenzo Dattilo; Mariangela Scalise; Massimo Gentile; Eleonora Vecchio; Nancy Nisticò; Annamaria Aloisio; Erika De Sensi; Giuseppe Fiume; Ileana Quinto; Selena Mimmi
Journal:  Front Oncol       Date:  2021-06-18       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.